Pharmacokinetics of sodium meclofenamate in pre-ruminant cattle

被引:0
|
作者
Picco, EJ
David, DCD
Encinas, T
Rubio, MR
Boggio, JC
机构
[1] Univ Nacl Litoral, Fac Ciencias Vet, Catedra Farmacol, RA-3080 Esperanza, Argentina
[2] Univ Complutense Madrid, Sch Vet, Dept Pharmacol, E-28040 Madrid, Spain
关键词
calf; sodium meclofenamate; pharmacokinetic; pre-ruminant;
D O I
10.1590/S0102-09352004000600001
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The pharmacokinetic profile of sodium meclofenamate, a non-steroidal antiinflammatory drug, was determined in six pre-ruminant calves after intravenous and intramuscular administration at a dose of 2.2mg/kg of body weight. Meclofenamate concentrations were measured using a high performance liquid chromatography assay. The pharmacokinetics of sodium meclofenamate after intravenous and intramuscular administration to calves were characterised by a rapid distribution phase (t(1/2alpha)), 15.45+/-4.85min and 23.14+/-7.24min for the intravenous and intramuscular administration, respectively, followed by a longer elimination phase (t(1/2beta)) after intramuscular treatment (17.55+/-6.52h.). The apparent volume of distribution (V-d) of the drug after intravenous administration was moderate (0.72+/-0.12l/kg), and high (3.51+/-1.05l/kg,) after intramuscular administration. This can be explained by the flip-flop effect or by enterohepatic shunting. The bioavailability achieved after intramuscular administration was 61%.
引用
收藏
页码:695 / 700
页数:6
相关论文
共 36 条
  • [31] The effectiveness of a fixed-dose combination pour-on formulation of 1.25% fipronil and 2.5% fluazuron against economically important ectoparasites and associated pharmacokinetics in cattle
    Zanetti Lopes, Welber Daniel
    Chiummo, Rafael Marin
    Vettorato, Luis Fernando
    Rodrigues, Daniel de Castro
    Sonada, Rafael Bazaglia
    PARASITOLOGY INTERNATIONAL, 2017, 66 (05) : 627 - 634
  • [32] In vitro and in vivo evaluation of 3D printed sodium alginate/polyethylene glycol scaffolds for sublingual delivery of insulin: Preparation, characterization, and pharmacokinetics
    Erzengin, Sevdenur
    Guler, Ece
    Eser, Enfal
    Polat, Elif Beyzanur
    Gunduz, Oguzhan
    Cam, Muhammet Emin
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2022, 204 : 429 - 440
  • [33] Pharmacokinetics and safety of CT-P39 via auto-injector are comparable to reference omalizumab via pre-filled syringe
    Hasunuma, Tomoko
    Grattan, Clive
    Eto, Takashi
    Yagi, Michio
    Yazawa, Rie
    Kim, Sunghyun
    Bae, Yunju
    Kim, Suyoung
    Park, Jeong Eun
    Kim, Jongho
    Saini, Sarbjit
    IMMUNOTHERAPY, 2025, 17 (02) : 113 - 121
  • [34] A Randomised Controlled Trial Comparing the Pharmacokinetics and Tolerability of the Proposed Adalimumab Biosimilar MSB11022 Delivered via Autoinjector and Pre-filled Syringe in Healthy Subjects
    Sabet, Ahad
    Dickerson, Daniel S.
    Kunina, Eugenia E.
    Buccarello, Anna Lucia
    Monnet, Joelle
    RHEUMATOLOGY AND THERAPY, 2022, 9 (02) : 693 - 704
  • [35] A Randomised Controlled Trial Comparing the Pharmacokinetics and Tolerability of the Proposed Adalimumab Biosimilar MSB11022 Delivered via Autoinjector and Pre-filled Syringe in Healthy Subjects
    Ahad Sabet
    Daniel S. Dickerson
    Eugenia E. Kunina
    Anna Lucia Buccarello
    Joëlle Monnet
    Rheumatology and Therapy, 2022, 9 : 693 - 704
  • [36] Hydrogel-forming microarray patches with cyclodextrin drug reservoirs for long-acting delivery of poorly soluble cabotegravir sodium for HIV Pre-Exposure Prophylaxis
    Volpe-Zanutto, Fabiana
    Vora, Lalitkumar K.
    Tekko, Ismaiel A.
    McKenna, Peter E.
    Permana, Andi Dian
    Sabri, Akmal H.
    Anjani, Qonita K.
    McCarthy, Helen O.
    Paredes, Alejandro J.
    Donnelly, Ryan F.
    JOURNAL OF CONTROLLED RELEASE, 2022, 348 : 771 - 785